Gatti, M.; Cojutti, P.G.; Pascale, R.; Tonetti, T.; Laici, C.; Dell’Olio, A.; Siniscalchi, A.; Giannella, M.; Viale, P.; Pea, F.
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections. Antibiotics 2021, 10, 1311.
https://doi.org/10.3390/antibiotics10111311
AMA Style
Gatti M, Cojutti PG, Pascale R, Tonetti T, Laici C, Dell’Olio A, Siniscalchi A, Giannella M, Viale P, Pea F.
Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections. Antibiotics. 2021; 10(11):1311.
https://doi.org/10.3390/antibiotics10111311
Chicago/Turabian Style
Gatti, Milo, Pier Giorgio Cojutti, Renato Pascale, Tommaso Tonetti, Cristiana Laici, Alessio Dell’Olio, Antonio Siniscalchi, Maddalena Giannella, Pierluigi Viale, and Federico Pea.
2021. "Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections" Antibiotics 10, no. 11: 1311.
https://doi.org/10.3390/antibiotics10111311
APA Style
Gatti, M., Cojutti, P. G., Pascale, R., Tonetti, T., Laici, C., Dell’Olio, A., Siniscalchi, A., Giannella, M., Viale, P., & Pea, F.
(2021). Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections. Antibiotics, 10(11), 1311.
https://doi.org/10.3390/antibiotics10111311
